Trial Profile
Fampridine Pregnancy Exposure Registry.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Biogen
- 20 Nov 2015 Planned End Date changed from 1 Oct 2020 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 20 Nov 2015 Planned primary completion date changed from 1 Oct 2020 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 20 Nov 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.